Facial Injectables Market
Number of pages: 100 | Report Format: PDF | Published date: January 18, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 6.39 billion |
|
Revenue forecast in 2030 |
US$ 15.41 billion |
|
Growth Rate |
10.28% from 2022 to 2030 |
|
Base Year for Estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Product, Application, End user, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global facial injectables market was valued at US$ 6.39 billion in 2021 and is expected to register a revenue CAGR of 10.28% to reach US$ 15.41 billion by 2030.
Facial Injectables Market Fundamentals
Facial injectables are soft tissue fillers inserted into the skin at various depths to smooth out facial wrinkles, add volume to the face, and enhance facial characteristics. As the body gradually absorbs them, most wrinkle fillers are temporary. Hyaluronic acid, a naturally occurring polysaccharide found in skin and cartilage, makes up the majority of dermal fillers. Some people require more than one injection to gain the wrinkle-smoothing effect. The impact lasts for at least 6 months. Successful outcomes depend on the condition of the skin, the competence of practitioners, and the filler utilized. The level of activity in the area where the filler is injected significantly impacts how long it lasts, regardless of the type of material (organic or synthetic). Exercise and physically demanding tasks, such as manual labor, can increase blood flow and reduce the longevity of fillers.
[45584325]
Facial Injectables Market Dynamics
Growing emphasis of major consumers across developed and developing countries on looks has fueled the facial injectables market. Moreover, awareness about minimally invasive procedures has increased in the past few years owing to various beauty advertisements run by players. This factor is propelling the global market for facial injectables.
The duration of video chats has risen due to the ongoing COVID-19 pandemic. Due to this, there is a higher demand for aesthetic procedures, with Botox being one of the most widely used procedures. Due to the simplicity of recuperation while recuperating at home, patients are now choosing cosmetic procedures. As a result, the market experienced a surge in demand for facial injectables during the epidemic. Furthermore, this trend is expected to continue during the forecast period.
The growth of the facial injectable market is expected to be driven by the presence of well-established key players such as Allergan, Sinclair Pharma, and Galderma. These players offer a comprehensive injectable filler portfolio treating a broad range of skin indications, including wrinkles, pigmentation, lip plumping, and scars, restoring facial fullness, as well as enhancing facial contours.
Growing desire of people from all age groups to appear youthful and aesthetically pleasing is expected to fuel revenue growth in the market during the forecast period. Moreover, improving effectiveness of face injectables and increasing number of product approvals are estimated to drive revenue growth in the next few years.
The market revenue share is expected to register growth at a notable CAGR during the forecast period owing to factors such as rising disposable income and increasing awareness about cosmetic procedures across emerging countries.
However, the market may experience a sluggish revenue growth rate owing to constraints, such as stringent regulatory requirements for product approvals and potential risks of skin reactions, such as rashes and redness. High filler expenditures may result into decreased adoption, thereby obstructing revenue growth in the market. The market revenue for facial injectables may be significantly constrained by the adverse effects related to the usage of dermal injectables.
Facial Injectables Market Ecosystem
The global facial injectables market is analyzed from four perspectives: product, application, end-user, and region.
Facial Injectables Market by Product
[45252542]
Based on the product, the global facial injectables market is segmented into botulinum toxin (Botox), collagen, hyaluronic acid (HA), calcium hydroxylaptite (CaHA), fat injections, polymer filters, and others. The polymer filters segment is sub-segmented into polylactic acid and polymethylmethacrylate microspheres (PMMA).
The botulinum toxin (Botox) segment accounts for the highest revenue share of the global facial injectables market. This is attributed to high demand for these procedures owing to their ability to delay the effects of aging. The adoption of fillers and injectables has increased among middle-aged women.
The hyaluronic acid (HA) segment is expected to register a significant rise in the revenue CAGR during the forecast period. This can be attributed to the ability of hyaluronic acid to retain moisture in the skin and make the skin appear healthier.
Facial Injectables Market by Application
Based on the application, the global facial injectables market is segmented into aesthetics and therapeutics. The aesthetics segment is sub-segmented into facial line correction, lip augmentation, facelift, acne scar treatment, lipoatrophy treatment, and others.
The aesthetic segment dominates the global facial injectables market in terms of revenue share. This is attributed to rise in the usage of facial injectables for aesthetic operations, such as in the treatment of lip lines, facial wrinkles, and facial lines.
Facial Injectables Market by End-user
Based on the end-user, the global facial injectables market is segmented into hospitals and dermatological clinics.
The dermatological clinic segment accounts for the largest revenue share in the market. This can be attributed to the high volume of injectable face procedures performed in dermatology and cosmetology clinics. Furthermore, the adoption of these filters has increased in dermatological clinics as the procedure needs little or no downtime.
Facial Injectables Market by Region
Based on the region, the global facial injectables market is segmented into North America, Europe, Asia Pacific, and the rest of the world (RoW).
North America accounts for the largest revenue share of the global market in terms of revenue. The rise in the regional population and aesthetic demands are driving the treatment for scars, acne, and anti-aging, which is resulting in increase in the revenue growth of the region. Adoption of anti-aging treatments has increased significantly in the U.S. owing to rise in the desire of people in the country to look young.
The importance of aesthetic appearance has increased over the past decade. Moreover, there has been increase in the availability of non-invasive treatments. As a result, people are highly choosing to have these operations done. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked first in terms of non-surgical procedures performed globally. Injectables, such as hyaluronic acid and botulinum toxin, were among the most frequently used treatments. With over 7,000 plastic surgeons as of 2019, the country is backed by innovative treatment alternatives and surgeons. These factors are projected to drive revenue growth in the North America market during the forecast period.
Facial Injectables Market Competitive Landscape
The prominent companies operating in the global facial injectables market are:
Facial Injectables Market Strategic Developments
Facial injectables include collagen, calcium hydroxyapatite, and hyaluronic acid-based treatments, which help rejuvenate the skin by removing and reducing wrinkles, enhancing the lips, elevating scars, and reducing the volume of soft tissues.
Increasing demand for aesthetic appearance, raising awareness, and increased usage of minimally invasive facial treatment are the key drivers for the global facial injectables market revenue growth.
Ipsen, Merz Pharma, Suneva Medical, Inc., Medytox Inc., and Sinclair Pharma are the key companies operating the global facial injectables market.
The high cost, stringent regulatory requirements for products, and skin reactions, such as rashes and redness, are likely to constrain revenue growth of the market.
The global facial injectables market is expected to register a revenue CAGR of 10.28% during the forecast period.
*Insights on financial performance are subject to the availability of information in the public domain